Get the Stockscreener App
1.91
1.55%
-0.03
After Hours:
1.92
0.01
+0.52%
Durect Corp stock is traded at $1.91, with a volume of 930.45K.
It is down -1.55% in the last 24 hours and up +2.69% over the past month.
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.
See More
Previous Close:
$1.94
Open:
$1.92
24h Volume:
930.45K
Relative Volume:
0.91
Market Cap:
$59.31M
Revenue:
$8.59M
Net Income/Loss:
$-17.07M
P/E Ratio:
-3.1311
EPS:
-0.61
Net Cash Flow:
$-21.90M
1W Performance:
-1.55%
1M Performance:
+2.69%
6M Performance:
+141.77%
1Y Performance:
+20.13%
1-Day Range:
$1.90
$1.94
1-Week Range:
$1.90
$1.94
52-Week Range:
$0.4801
$2.64
Durect Corp Stock (DRRX) Company Profile
Name
Durect Corp
Sector
Phone
(408) 777-1417
Address
10240 BUBB ROAD, CUPERTINO, CA
Compare DRRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRRX
Durect Corp
|
1.91 | 60.25M | 8.59M | -17.07M | -21.90M | -0.61 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Durect Corp Stock (DRRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-30-20 | Initiated | Chardan Capital Markets | Buy |
| Oct-12-20 | Initiated | ROTH Capital | Buy |
| Jul-31-20 | Initiated | Oppenheimer | Outperform |
| Jan-31-20 | Initiated | B. Riley FBR | Buy |
| Nov-18-19 | Resumed | Cantor Fitzgerald | Overweight |
| Sep-06-19 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-06-18 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Oct-20-17 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-20-17 | Reiterated | Laidlaw | Buy |
| Oct-20-17 | Downgrade | Stifel | Buy → Hold |
| Jul-12-17 | Upgrade | Stifel | Hold → Buy |
| Feb-28-17 | Resumed | H.C. Wainwright | Buy |
| Apr-25-16 | Initiated | Rodman & Renshaw | Buy |
| May-01-15 | Reiterated | Cantor Fitzgerald | Buy |
| May-01-15 | Reiterated | Stifel | Buy |
| Mar-25-13 | Initiated | Stifel | Buy |
| Nov-01-12 | Downgrade | C.K. Cooper | Buy → Hold |
| Aug-17-12 | Initiated | C.K. Cooper | Buy |
| Jun-23-09 | Initiated | Caris & Company | Buy |
| Mar-26-09 | Initiated | Wedbush Morgan | Hold |
View All
Durect Corp Stock (DRRX) Latest News
Will DURECT Corporation outperform its industry peersMarket Trend Review & Free Risk Controlled Daily Trade Plans - khodrobank.com
Will DURECT Corporation continue its uptrendMarket Volume Report & Expert Curated Trade Setups - Newser
Key metrics from DURECT Corporation’s quarterly dataJuly 2025 Breakouts & Safe Swing Trade Setups - Newser
Short interest data insights for DURECT CorporationPortfolio Growth Summary & Daily Technical Stock Forecast Reports - Newser
Pattern recognition hints at DURECT Corporation upsideInsider Buying & Short-Term Trading Alerts - Newser
What’s next for DURECT Corporation stock price2025 Major Catalysts & Verified High Yield Trade Plans - Newser
How high can DURECT Corporation stock go2025 Top Gainers & Fast Gaining Stock Reports - Newser
Can DURECT Corporation be recession proofMarket Movement Recap & Smart Allocation Stock Tips - khodrobank.com
Smart tools for monitoring DURECT Corporation’s price action2025 Pullback Review & AI Powered Market Trend Analysis - Newser
DURECT Corporation’s volatility index tracking explainedMarket Trend Review & Daily Stock Momentum Reports - Newser
Can a trend reversal in DURECT Corporation lead to recoveryWeekly Profit Analysis & Technical Pattern Recognition Alerts - Newser
Smart Money: What is DURECT Corporation’s market position2025 Technical Overview & Weekly Consistent Profit Watchlists - khodrobank.com
Will DURECT Corporation outperform the market2025 Investor Takeaways & Daily Price Action Insights - Newser
Can DURECT Corporation deliver alpha2025 Market Sentiment & Real-Time Volume Surge Alerts - khodrobank.com
Is DURECT Corporation stock ready for a breakoutMarket Activity Report & Safe Investment Capital Preservation Plans - Newser
Can volume confirm reversal in DURECT Corporation2025 Sector Review & Short-Term High Return Strategies - Newser
What does recent volatility data suggest for DURECT CorporationMarket Performance Recap & Safe Entry Momentum Tips - Newser
Applying Elliott Wave Theory to DURECT CorporationWeekly Trade Report & Low Risk Entry Point Guides - Newser
Bull Bear: Can DURECT Corporation be recession proof2025 Risk Factors & High Return Trade Guides - sundaytimes.kr
Signal strength of DURECT Corporation stock in tech scannersMarket Volume Summary & Consistent Return Investment Signals - Newser
Momentum divergence signals in DURECT Corporation chartTrade Analysis Report & Proven Capital Preservation Methods - Newser
Can DURECT Corporation lead its sector in growth getLinesFromResByArray error: size == 0 - sisain.net
Bausch Health Companies Inc. (BHC) Expands Hepatology Portfolio with DURECT Acquisition - Insider Monkey
Durect Corp Stock (DRRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Durect Corp Stock (DRRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ASEN R SCOTT | 10% Owner |
Aug 21 '25 |
Buy |
1.90 |
116,612 |
221,306 |
2,666,612 |
| ASEN R SCOTT | 10% Owner |
Aug 20 '25 |
Buy |
1.89 |
87,608 |
165,360 |
970,000 |
3.60%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):